We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+10.19%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$125B
AUM Growth
+$7.74B
(+6.6%)
Cap. Flow
-$1.18B
Cap. Flow
% of AUM
-0.95%
Top 10 Holdings %
Top 10 Hldgs %
32.47%
Holding
4,267
New
79
Increased
1,134
Reduced
2,614
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$80.1M |
| 2 |
Chevron
CVX
|
+$75.4M |
| 3 |
Robinhood
HOOD
|
+$52.2M |
| 4 |
Nutanix
NTNX
|
+$32.2M |
| 5 |
Datadog
DDOG
|
+$29.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$166M |
| 2 |
Apple
AAPL
|
+$150M |
| 3 |
NVIDIA
NVDA
|
+$148M |
| 4 |
HES
Hess
HES
|
+$72.3M |
| 5 |
ANSS
Ansys
ANSS
|
+$59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.89% |
| 2 | Financials | 13.4% |
| 3 | Consumer Discretionary | 10.96% |
| 4 | Communication Services | 9.45% |
| 5 | Healthcare | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
NRC Health Common Stock
NRC
$450M
| $264K | ﹤0.01% |
20,683
-1,091
| -5% | -$16.4K |
|
2877
Copel
ELPC
$8.57B
| $264K | ﹤0.01% |
29,499
-21,624
| -42% | -$179K |
|
2878
Ryanair
RYAAY
$31.3B
| $264K | ﹤0.01% |
4,380
+685
| +19% | +$41.8K |
|
2879
Blue Ridge Bankshares
BRBS
$332M
| $263K | ﹤0.01% |
62,213
+877
| +1% | +$3.4K |
|
2880
US Gold Corp
USAU
$258M
| $261K | ﹤0.01% |
15,859
+643
| +4% | +$8.2K |
|
2881
Allogene Therapeutics
ALLO
$694M
| $261K | ﹤0.01% |
210,726
+1,390
| +0.7% | +$1.66K |
|
2882
Neurogene
NGNE
$712M
| $261K | ﹤0.01% |
15,059
-266
| -2% | -$5.34K |
|
2883
iShares MSCI Netherlands ETF
EWN
$713M
| $260K | ﹤0.01% |
4,478
| – | – |
|
2884
Holley
HLLY
$384M
| $259K | ﹤0.01% |
82,386
-20,901
| -20% | -$62.3K |
|
2885
NACCO Industries
NC
$320M
| $258K | ﹤0.01% |
6,121
-1,334
| -18% | -$52.9K |
|
|
FUJI
2886
DELISTED
FUJI FILM HOLDINGS ADR 2 ORD
FUJI
| $258K | ﹤0.01% |
20,860
-6,235
| -23% | -$77K |
|
2887
OmniAb
OABI
$447M
| $257K | ﹤0.01% |
160,936
+208
| +0.1% | +$380 |
|
2888
iShares Russell 2000 Value ETF
IWN
$14.6B
| $257K | ﹤0.01% |
1,453
+316
| +28% | +$53.3K |
|
2889
Velocity Financial
VEL
$729M
| $257K | ﹤0.01% |
14,141
-1,176
| -8% | -$21.5K |
|
2890
Alta Equipment Group
ALTG
$245M
| $255K | ﹤0.01% |
35,228
-934
| -3% | -$7.26K |
|
2891
Coherus Oncology
CHRS
$196M
| $255K | ﹤0.01% |
155,276
+1,899
| +1% | +$2.11K |
|
2892
Core Molding Technologies
CMT
$234M
| $254K | ﹤0.01% |
12,376
-271
| -2% | -$5.03K |
|
2893
First National Corp
FXNC
$287M
| $254K | ﹤0.01% |
11,197
+974
| +10% | +$21.6K |
|
|
VOXR
2894
Vox Royalty Corp
VOXR
$347M
| $254K | ﹤0.01% |
59,050
+11,209
| +23% | +$38.5K |
|
2895
Medallion Financial
MFIN
$250M
| $253K | ﹤0.01% |
25,088
-4,624
| -16% | -$47.1K |
|
2896
Montauk Renewables
MNTK
$255M
| $253K | ﹤0.01% |
125,712
+19,831
| +19% | +$42.5K |
|
2897
Smith & Nephew
SNN
$12.6B
| $252K | ﹤0.01% |
6,945
-904
| -12% | -$31.2K |
|
|
RSVR
2898
Reservoir Media
RSVR
$667M
| $251K | ﹤0.01% |
30,881
+1,177
| +4% | +$9.2K |
|
|
TECX
2899
Tectonic Therapeutic
TECX
$606M
| $251K | ﹤0.01% |
15,993
+18
| +0.1% | +$371 |
|
2900
Brookfield
BN
$108B
| $250K | ﹤0.01% |
5,475
| – | – |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2025 Portfolio in Review
As of Q3 2025, RhumbLine Advisers held 4,267 positions worth $125B, up 6.6% from $117B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q3 2025: portfolio turnover was 4.2%. RhumbLine Advisers opened 79 new positions and exited 100, leaving the 4,267-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- RhumbLine Advisers's largest Q3 2025 buy was The Marzetti Company: 64,390 shares worth $11.1M.
- RhumbLine Advisers added most to Applovin in Q3 2025, an estimated $80.1M increase.
- RhumbLine Advisers's biggest Q3 2025 reduction was Microsoft, cutting an estimated $166M.
- RhumbLine Advisers fully exited Hess in Q3 2025, selling an estimated $72.3M.
- RhumbLine Advisers's ten largest holdings make up 32% of its $125B portfolio in Q3 2025.
- RhumbLine Advisers opened 79 new positions and closed 100 in Q3 2025.
- RhumbLine Advisers's portfolio value rose 6.6% quarter-over-quarter to $125B.
Based on RhumbLine Advisers's 13F filing for Q3 2025, filed 6 Nov 2025.